The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 10, Pages 1361-1377
Publisher
Informa Healthcare
Online
2015-06-30
DOI
10.1517/14728222.2015.1062475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
- (2015) Oncotarget
- Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
- (2014) J.- C. Soria et al. ANNALS OF ONCOLOGY
- Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance
- (2014) Zhongwei Cao et al. CANCER CELL
- Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity
- (2014) Kazuyo Yasuda et al. LABORATORY INVESTIGATION
- Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis
- (2014) Sunday S. Oladipupo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
- (2013) R. Dienstmann et al. ANNALS OF ONCOLOGY
- Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties
- (2013) Françoise Bono et al. CANCER CELL
- Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression
- (2013) S. Feng et al. CANCER RESEARCH
- Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3
- (2013) Y. Yin et al. CANCER RESEARCH
- Small molecule inhibition of fibroblast growth factor receptors in cancer
- (2013) Guang Liang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma
- (2013) Jiyeon Hyeon et al. DIGESTIVE DISEASES AND SCIENCES
- Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations
- (2013) Han Kiat Ho et al. DRUG DISCOVERY TODAY
- FGF16 Promotes Invasive Behavior of SKOV-3 Ovarian Cancer Cells through Activation of Mitogen-activated Protein Kinase (MAPK) Signaling Pathway
- (2013) Moitri Basu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGF18 as a prognostic and therapeutic biomarker in ovarian cancer
- (2013) Wei Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer
- (2013) Roberto Ronca et al. JOURNAL OF PATHOLOGY
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- Long Pentraxin-3 Inhibits Epithelial-Mesenchymal Transition in Melanoma Cells
- (2013) R. Ronca et al. MOLECULAR CANCER THERAPEUTICS
- FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
- (2013) Alberto Peláez-García et al. PLoS One
- Blockade of Nonhormonal Fibroblast Growth Factors by FP-1039 Inhibits Growth of Multiple Types of Cancer
- (2013) T. C. Harding et al. Science Translational Medicine
- High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast
- (2013) Abdelbaset Buhmeida et al. TUMOR BIOLOGY
- Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
- (2013) Maria Vittoria Dieci et al. Cancer Discovery
- Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR
- (2012) Daniela Coltrini et al. ANGIOGENESIS
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor
- (2012) Cristina Ferreras et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The Thymidine Phosphorylase Inhibitor 5'-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist
- (2012) S. Liekens et al. MOLECULAR CANCER THERAPEUTICS
- Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis
- (2012) Monika Jarosz et al. PLoS One
- Anticancer molecules targeting fibroblast growth factor receptors
- (2012) Guang Liang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition
- (2011) Thomas Metzner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
- (2011) D. Leali et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells
- (2011) Matthew J Frontini et al. NATURE BIOTECHNOLOGY
- Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo
- (2010) Kazuhiro Kunimasa et al. CANCER SCIENCE
- Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
- (2010) Christine Gauglhofer et al. HEPATOLOGY
- Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors
- (2010) Giorgio Colombo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide
- (2010) Xiang Chen et al. JOURNAL OF CONTROLLED RELEASE
- Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
- (2010) R. Ronca et al. MOLECULAR CANCER THERAPEUTICS
- Fgf-9 is required for angiogenesis and osteogenesis in long bone repair
- (2010) B. Behr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocrine fibroblast growth factors as regulators of metabolic homeostasis
- (2009) Hiroshi Kurosu et al. BIOFACTORS
- Signal Transducers and Activators of Transcription Mediate Fibroblast Growth Factor–Induced Vascular Endothelial Morphogenesis
- (2009) Xinhai Yang et al. CANCER RESEARCH
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking
- (2009) Chiara Francavilla et al. JOURNAL OF CELL BIOLOGY
- Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide
- (2009) Daria Leali et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
- (2009) M. Shawkat Razzaque Nature Reviews Endocrinology
- Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer
- (2009) M. Sheffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sprouty proteins, masterminds of receptor tyrosine kinase signaling
- (2008) Miguel A. Cabrita et al. ANGIOGENESIS
- FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer
- (2008) S Nomura et al. BRITISH JOURNAL OF CANCER
- The role of bone in phosphate metabolism
- (2008) Seiji Fukumoto MOLECULAR AND CELLULAR ENDOCRINOLOGY
- FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities
- (2008) S Allerstorfer et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started